ARW vs OTEX

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of just 3/9, indicating significant concerns in profitability, leverage, and operating efficiency. Despite this, the company shows resilience through solid revenue growth (13% YoY), consistent earnings beats (25.62% average surprise over last 4 quarters), and a reasonable Debt/Equity ratio of 0.48. Valuation appears attractive relative to peers with a P/E of 13.08 versus sector average of 89.76 and a Price/Book under 1, though low margins and declining recent EPS growth (-0.8% QoQ) temper optimism. The stock trades below its Graham Number ($157.92) and intrinsic value estimate ($212.3), suggesting potential undervaluation, but weak profitability metrics and lack of Altman Z-Score data limit confidence in financial stability.

OTEX presents a classic value trap profile: fundamentally cheap but lacking growth catalysts. The Piotroski F-Score of 5/9 indicates stable financial health, and the stock currently trades below its Graham Number ($25.5), suggesting a defensive margin of safety. However, this is offset by alarming growth metrics, including a -23.90% YoY earnings decline and a technical trend score of 0/100. While the dividend yield is attractive, the combination of high debt (D/E 1.63) and poor liquidity (Current Ratio 0.94) warrants caution.